During this recorded presentation brought to you by Boehringer Ingelheim and Covetrus, Dr. Daniel Joffe, DVM, DABVP discusses recommendations on enhancing NSAID safety, concerns with concurrent therapy, advice on dosing and titration, as well as the pros and cons of generic NSAID options.
Please note: in order to be eligible for CE, you must have attended the live webinar, held on Wednesday, October 14, 2020.